Addiction

Article	Citations
Mitigating and learning from the impact of COVID‐19 infection on addictive disorders	192
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)	184
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data	165
Gateway or common liability? A systematic review and meta‐analysis of studies of adolescent e‐cigarette use and future smoking initiation	110
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis	110
Expert appraisal of criteria for assessing gaming disorder: an international Delphi study	108
Alcohol consumption during the COVID‐19 pandemic in Europe: a large‐scale cross‐sectional study in 21 countries	98
African Americans now outpace whites in opioid‐involved overdose deaths: a comparison of temporal trends from 1999 to 2018	95
Shifts in alcohol consumption during the COVID‐19 pandemic: early indications from Australia	88
Drug checking services for people who use drugs: a systematic review	84
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross‐sectional study	79
Associations between solitary drinking and increased alcohol consumption, alcohol problems, and drinking to cope motives in adolescents and young adults: a systematic review and meta‐analysis	73
Heroin use cannot be measured adequately with a general population survey	68
Treatment rates for alcohol use disorders: a systematic review and meta‐analysis	66
A meta‐analysis of problem gambling risk factors in the general adult population	62
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration	58
Causal mechanisms proposed for the alcohol harm paradox—a systematic review	52
Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States	50
Alcohol use in pregnancy and its impact on the mother and child	50
Global opioid agonist treatment: a review of clinical practices by country	49
Changes in alcohol consumption associated with social distancing and self‐isolation policies triggered by COVID‐19 in South Australia: a wastewater analysis study	49
COVID‐19, smoking, vaping and quitting: a representative population survey in England	48
Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England	47
Behaviour change techniques associated with smoking cessation in intervention and comparator groups of randomized controlled trials: a systematic review and meta‐regression	47
The associations between prenatal cannabis use disorder and neonatal outcomes	47

Electronic cigarettes, nicotine use trends and use initiation ages among US adolescents from 1999 to 2018	46
Lessons from the public health responses to the US outbreak of vaping‐related lung injury	45
Text messaging interventions for reducing alcohol consumption among risky drinkers: systematic review and meta‐analysis	43
Similar countries, similar factors? Studying the decline of heavy episodic drinking in adolescents in Finland, Norway and Sweden	43
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?	43
The unique nature of public stigma toward non‐medical prescription opioid use and dependence: a national study	40
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA	40
Outcomes associated with the use of medications for opioid use disorder during pregnancy	39
Emotion regulation in substance use disorders: a systematic review and meta‐analysis	39
Unknown population‐level harms of cannabis and tobacco co‐use: if you don't measure it, you can't manage it	39
Bidirectional effects between loneliness, smoking and alcohol use: evidence from a Mendelian randomization study	39
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use	38
Technology‐mediated just‐in‐time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review	38
The science of recovery capital: where do we go from here?	38
Controlled drinking—non‐abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta‐analysis and meta‐regression	37
Alcohol control policy measures and all‐cause mortality in Lithuania: an interrupted time–series analysis	37
Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies	37
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	36
The association between recreational cannabis legalization, commercialization and cannabis‐attributable emergency department visits in Ontario, Canada: an interrupted time–series analysis	35
Changes in drinking days among United States adults during the COVID‐19 pandemic	35
For better or for worse? A pre–post exploration of the impact of the COVID‐19 lockdown on cannabis users	35
Dependence on e‐cigarettes and cigarettes in a cross‐sectional study of US adults	35
Frequency of use, moral incongruence and religiosity and their relationships with self‐perceived addiction to pornography, internet use, social networking and online gaming	34
Factors associated with severity, incidence or persistence of internet gaming disorder in children and adolescents: a 2‐year longitudinal study	34
Laws limiting prescribing and dispensing of opioids in the United States, 1989–2019	34
Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non‐drinking?	33
Alcohol use disorder and the liver	33
Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study	33
Carfentanil and the rise and fall of overdose deaths in the United States	32
Risk of overdose‐related death for people with a history of incarceration	32
Cannabis use and co‐use in tobacco smokers and non‐smokers: prevalence and associations with mental health in a cross‐sectional, nationally representative sample of adults in Great Britain, 2020	31
Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis	31
The dawn of a new synthetic opioid era: the need for innovative interventions	31
Tobacco Use and Oral Health	31
Impact of health warning labels communicating the risk of cancer on alcohol selection: an online experimental study	31
The real‐world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine	30
Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses	30
Cannabis use disorder and the lungs	30
The relationship between cannabis and schizophrenia: a genetically informed perspective	30
Alcohol use among young Australian adults in May–June 2020 during the COVID‐19 pandemic: a prospective cohort study	30
Trends in cannabis use among adults with children in the home in the United States, 2004–2017: impact of state‐level legalization for recreational and medical use	30
Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP	30
Changes in illicit drug use and markets with the COVID‐19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016–20	29
Iterative categorisation (IC) (part 2): interpreting qualitative data	29
Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network	29
Cognitive boosting interventions for impulsivity in addiction: a systematic review and meta‐analysis of cognitive training, remediation and pharmacological enhancement	28
E‐cigarettes versus nicotine replacement treatment as harm reduction interventions for smokers who find quitting difficult: randomized controlled trial	28
The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta‐analysis	28
Trends in electronic cigarette use and conventional smoking: quantifying a possible ‘diversion’ effect among US adolescents	28
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial	28

A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy	28
Food addiction in a large community sample of Canadian adults: prevalence and relationship with obesity, body composition, quality of life and impulsivity	27
A life‐course theory exploration of opioid‐related maternal mortality in the United States	27
Evaluating the impact of minimum unit pricing (MUP) on off‐trade alcohol sales in Scotland: an interrupted time–series study	27
Youth use of e‐liquid flavours—a systematic review exploring patterns of use of e‐liquid flavours and associations with continued vaping, tobacco smoking uptake or cessation	27
Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial	27
Clinical management of cannabis withdrawal	27
Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community drug services: real‐world d	26
Concurrent validity of the Alcohol Purchase Task for measuring the reinforcing efficacy of alcohol: an updated systematic review and meta‐analysis	26
Highly processed foods can be considered addictive substances based on established scientific criteria	26
Is Cannabis being used as a substitute for non‐medical opioids by adults with problem substance use in the United States? A within‐person analysis	26
Clarifying gambling subtypes: the revised pathways model of problem gambling	26
Global prevalence of help‐seeking for problem gambling: A systematic review and meta‐analysis	25
Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta‐analysis	25
Cross‐national validation of the social media disorder scale: findings from adolescents from 44 countries	25
Culturally tailored evidence‐based substance use disorder treatments are efficacious with an American Indian Southwest tribe: an open‐label pilot‐feasibility randomized controlled trial	25
Associations between neighborhood‐level factors and opioid‐related mortality: A multi‐level analysis using death certificate data	24
Internet‐based therapy versus face‐to‐face therapy for alcohol use disorder, a randomized controlled non‐inferiority trial	24
Tobacco use disorder and cardiovascular health	24
Alcohol: a probable risk factor of COVID‐19 severity	24
Associations between financial gambling motives, gambling frequency and level of problem gambling: a meta‐analytic review	24
Dual‐trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study	24
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials	23
Reducing craving and consumption in individuals with drug addiction, obesity or overeating through neuromodulation intervention: a systematic review and meta‐analysis of its follow‐up effects	23
When the pubs closed: beer consumption before and after the first and second waves of COVID‐19 in Australia	23
Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four‐Country survey (2002–14)	23
Sex differences in factors predicting post‐treatment opioid use	22
Societal development and the alcohol‐attributable burden of disease	22
Adolescent cannabis and tobacco use are associated with opioid use in young adulthood—12‐year longitudinal study in an urban cohort	22
Clinical management of the alcohol withdrawal syndrome	22
Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014–18	22
Association of smoking, lung function and COPD in COVID‐19 risk: a two‐step Mendelian randomization study	22
Predictors of recruitment and retention in randomized controlled trials of behavioural smoking cessation interventions: a systematic review and meta‐regression analysis	22
A randomized clinical trial of a group cognitive–behavioral therapy to reduce alcohol use among human immunodeficiency virus‐infected outpatients in western Kenya	22
A systematic review and meta‐analysis on the association between solitary drinking and alcohol problems in adults	22
Are psychosocial interventions effective in reducing alcohol consumption during pregnancy and motherhood? A systematic review and meta‐analysis	21
Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries	21
Cross‐country differences in age trends in alcohol consumption among older adults: a cross‐sectional study of individuals aged 50 years and older in 22 countries	21
A cluster randomized controlled trial evaluating the effectiveness of the school‐based drug prevention program #Tamojunto2.0	21
All‐cause and cause‐specific mortality among people with regular or problematic cocaine use: a systematic review and meta‐analysis	21
Efficacy of brief intervention for harmful and hazardous alcohol use: a systematic review and meta‐analysis of studies from low middle‐income countries	21
Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021	21
Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta‐analysis	20
Biomarkers of potential harm in people switching from smoking tobacco to exclusive e‐cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e‐cigarettes f	20
Effect of extended‐release naltrexone on alcohol consumption: a systematic review and meta‐analysis	20
Jail and overdose: assessing the community impact of incarceration on overdose	20
Weeding out the truth: a systematic review and meta‐analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence	20
Efficacy of non‐invasive brain stimulation interventions in reducing smoking frequency in patients with nicotine dependence: a systematic review and network meta‐analysis of randomized controlled tria	20
The Stop‐tabac smartphone application for smoking cessation: a randomized controlled trial	20
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings	20
Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study	20
Using ecological momentary assessment (EMA) to explore mechanisms of alcohol‐involved HIV risk behavior among men who have sex with men (MSM)	20
Adolescent electronic cigarette use and tobacco smoking in the Millennium Cohort Study	20
Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study	20
Alcohol use disorder and the gut	19
Changes in alcohol‐related hospital visits during COVID‐19 in New York City	19
The long‐term effectiveness of universal, selective and combined prevention for alcohol use during adolescence: 36‐month outcomes from a cluster randomized controlled trial	19
The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom	19
Effect of screening, brief intervention and referral to treatment for unhealthy alcohol and other drug use in mental health treatment settings: a randomized controlled trial	19
Injecting drug use, the skin and vasculature	19
Estimating the prevalence of problem drug use from drug‐related mortality data	19
Frequency of adolescent cannabis smoking and vaping in the United States: Trends, disparities and concurrent substance use, 2017–19	19
The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study	19
Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society	19
Evaluating the effectiveness of the smartphone app, Drink Less, compared with the NHS alcohol advice webpage, for the reduction of alcohol consumption among hazardous and harmful adult drinkers in the	19
A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder	18
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	18
Prevalence of alcohol use disorder among individuals who binge eat: a systematic review and meta‐analysis	18
Drinking risk varies within and between Australian Aboriginal and Torres Strait Islander samples: a meta‐analysis to identify sources of heterogeneity	18
Changes from 2017 to 2018 in e‐cigarette use and in ever marijuana use with e‐cigarettes among US adolescents: analysis of the National Youth Tobacco Survey	17
Mortality among people who inject drugs: a prospective cohort followed over three decades in Baltimore, MD, USA	17
Psychosocial interventions for reducing alcohol consumption in sub‐Saharan African settings: a systematic review and meta‐analysis	17
Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and	17
Young adult responses to taxes on cigarettes and electronic nicotine delivery systems	17
E‐cigarette regulation: a delicate balance for public health	17
Joint effects of alcohol use, smoking and body mass index as an explanation for the alcohol harm paradox: causal mediation analysis of eight cohort studies	17
Prenatal methamphetamine—impact on the mother and child—a review	17
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database	17
Association between poverty exposure during childhood and adolescence, and drug use disorders and drug‐related crimes later in life	17
Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis	17

Effects of interventions to combat tobacco addiction: Cochrane update of 2019 and 2020 reviews	17
Setting Limits: Gambling, Science and Public Policy—summary of results	16
Impacts of Canada's cannabis legalization on police‐reported crime among youth: early evidence	16
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	16
A difference‐in‐difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004–17	16
Assessing New Zealand’s Cannabis Legalization and Control Bill: prospects and challenges	16
A new generation of transdermal alcohol biosensing technology: practical applications, machine ‐learning analytics and questions for future research	16
Coordination, framing and innovation: the political sophistication of public health advocates in Ireland	16
Tracking the decline in Australian adolescent drinking into adulthood	16
Content analysis of cannabis vaping videos on YouTube	16
Alcohol: No Ordinary Commodity—a summary of the third edition	16
Health warning labels and alcohol selection: a randomised controlled experiment in a naturalistic shopping laboratory	15
Loot boxes are more prevalent in United Kingdom video games than previously considered: updating Zendle et al. (2020)	15
All‐cause and suicide mortality among people with methamphetamine use disorder: a nation‐wide cohort study in Taiwan	15
Supporting smoking cessation and preventing relapse following a stay in a smoke‐free setting: a meta‐analysis and investigation of effective behaviour change techniques	15
The impact of changes in COVID‐19 lockdown restrictions on alcohol consumption and drinking occasion characteristics in Scotland and England in 2020: an interrupted time‐series analysis	15
The effect of tobacco and alcohol consumption on poverty in the United Kingdom	15
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an em	15
Genome‐wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci	15
Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters	15
Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review	15
Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study	15
Prevalence of co‐occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada	15
Trends in marijuana use in two Latin American countries: an age, period and cohort study	15
Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial	14
Drug‐related harm coinciding with income assistance payments: results from a community‐based cohort of people who use drugs	14
Tobacco use during pregnancy	14
The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual‐participant data from 15 international studies	14
Community‐based smoking cessation treatment for adults with high anxiety sensitivity: a randomized clinical trial	14
Encouraging and evaluating limit‐setting among on‐line gamblers: a naturalistic randomized controlled trial	14
Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study	14
Meta‐analysis of associations between empathy and alcohol use and problems in clinical and non‐clinical samples	14
Rapid changes in illegally manufactured fentanyl products and prices in the United States	14
Alcohol policy and gender: a modelling study estimating gender‐specific effects of alcohol pricing policies	14
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study	14
The associations of smoking dependence motives with depression among daily smokers	14
Benzodiazepines: the time for systematic change is now	14
A wastewater‐based assessment of the impact of a minimum unit price (MUP) on population alcohol consumption in the Northern Territory, Australia	14
Reward‐related decision‐making deficits in internet gaming disorder: a systematic review and meta‐analysis	14
Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta‐analysis	14
Availability of medical cannabis dispensaries and cannabis abuse/dependence‐related hospitalizations in California	14
Causal inference with observational data in addiction research	14
Is substance use changing because of the COVID‐19 pandemic? Conceptual and methodological considerations to delineating the impact of the COVID‐19 pandemic on substance use and disorder	14
Does heroin‐assisted treatment reduce crime? A review of randomized‐controlled trials	14
Delta‐8 tetrahydrocannabinol: a scoping review and commentary	13
Need for comprehensive and timely data to address the opioid overdose epidemic without a blindfold	13
Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod‐based e‐cigarettes	13
Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes	13
Age‐based preferences for risk communication in the fentanyl era: ‘A lot of people keep seeing other people die and that's not enough for them’	13
#TurntTrending: a systematic review of substance use portrayals on social media platforms	13
Association of e‐cigarette advertising with e‐cigarette and cigarette use among US adults	13
Home delivery of legal intoxicants in the age of COVID‐19	13
The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic	13
A first pass, using pre‐history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems, 1970s–c. 2018	13
Regulation and accreditation of addictive behaviour applications—navigating the landscape	13
Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial	13
The association of telomere length with substance use disorders: a systematic review and meta‐analysis of observational studies	13
England SimSmoke: the impact of nicotine vaping on smoking prevalence and smoking‐attributable deaths in England	13
Alcohol use in the year following approach bias modification during inpatient withdrawal: secondary outcomes from a double‐blind, multi‐site randomized controlled trial	13
Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis	13
Telephone‐based motivational interviewing enhanced with individualised personality‐specific coping skills training for young people with alcohol‐related injuries and illnesses accessing emergency or r	13
The theory of collectivity of drinking cultures: how alcohol became everyone's problem	13
Opioid overdose experiences in a sample of US adolescents and young adults: a thematic analysis	13
Illicit drug use and oral health	13
Skin‐cleaning among hospitalized people who inject drugs: a randomized controlled trial	13
A systematic review of qualitative research on substance use among refugees	13
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?	13
The impact of comprehensive tobacco control policies on cardiovascular diseases in Beijing, China	13
Genetic architecture of four smoking behaviors using partitioned SNP heritability	13
User pathways of e‐cigarette use to support long term tobacco smoking relapse prevention: a qualitative analysis	13
Association of vaping‐related lung injuries with rates of e‐cigarette and cannabis use across US states	12
Trends in cannabis use and attitudes toward legalization and use among Australians from 2001–2016: an age‐period‐cohort analysis	12
Aberrations in peripheral inflammatory cytokine levels in substance use disorders: a meta‐analysis of 74 studies	12
Alcohol use and cognitive functioning in young adults: improving causal inference	12
Comparison of a web‐push survey research protocol with a mailed paper and pencil protocol in the Monitoring the Future panel survey	12
Alcohol use disorder and non‐fatal suicide attempt: findings from a Swedish National Cohort Study	12
Impact of bottle size on in‐home consumption of wine: a randomized controlled cross‐over trial	12
Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients	12
Opioid use disorder and the brain: a clinical perspective	12
Addicted to smoking or addicted to nicotine? A focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non‐smokers and dual users of cigarettes and e	12
Prevalence and correlates of receptive syringe‐sharing among people who inject drugs in rural Appalachia	12
Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID‐19 pandemic in New South Wales, Australia	12
Kratom use in the United States: a diverse and complex profile	12
Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses	12
Association of quarterly prevalence of e‐cigarette use with ever regular smoking among young adults in England: a time–series analysis between 2007 and 2018	12
Prices, taxes and alcohol use: a systematic umbrella review	12
Comparison of e‐cigarette use prevalence and frequency by smoking status among youth in the United States, 2014–19	12
Are you for real? Maximizing participant eligibility on Amazon's Mechanical Turk	12
Affected other interventions: a systematic review and meta‐analysis across addictions	12
Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID‐19	12
Clinical Management of Opioid Withdrawal	12
Association between punitive policies and neonatal abstinence syndrome among Medicaid‐insured infants in complex policy environments	12
Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV‐negative men who have sex with men	12
The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community	12
Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use	12